CurrentEndo
Get Weekly

CurrentEndo coverage · page 9 of 12

Diabetes Technology & Therapeutics

Briefs 321–360 of 475 CurrentEndo has covered from this journal, newest publication first

Latest from Diabetes Technology & Therapeutics

All coverage, newest first

  1. Diabetes Technol Ther

    Development of Machine Learning Models for the Identification of Elevated Ketone Bodies During Hyperglycemia in Patients with Type 1 Diabetes

    Research articleT1D

  2. Diabetes Technol Ther

    Clinical Outcomes with MiniMed TM 780G Advanced Hybrid Closed-Loop Therapy in 2- to 6-Year-Old Children with Type 1 Diabetes

    Research articleTechnology

  3. Diabetes Technol Ther

    Continuous Glucose Monitoring Alarms in Adults with Type 1 Diabetes: User Characteristics and the Impact of Hypoglycemia and Hyperglycemia Alarm Thresholds on Glycemic Control

    Cross-sectional studyTechnology

  4. Diabetes Technol Ther

    Assessment of the Impact of Subcutaneous Catheter Change on Glucose Control in Patients with Type 1 Diabetes Treated by Insulin Pump in Open- and Closed-Loop Modes

    Cohort studyTechnology

  5. Diabetes Technol Ther

    Evaluation of Glucose Metrics in Adults with Type 1 Diabetes Switching to Insulin Glargine 300 U/mL: A Retrospective, Propensity-Score Matched Study

    Cohort studyT1D

  6. Diabetes Technol Ther

    Driving-Related Glucose Patterns Among Older Adults with Type 1 Diabetes

    Cohort studyTechnology

  7. Diabetes Technol Ther

    Performance of the Dexcom G7 Continuous Glucose Monitoring System in Pregnant Women with Diabetes

    Diagnostic or prognostic studyDiabetes in pregnancy

  8. Diabetes Technol Ther

    Real-world evidence of off-label use of commercially automated insulin delivery systems compared to multiple daily insulin injections in pregnancies complicated by type 1 diabetes

    Cohort studyDiabetes in pregnancy

  9. Diabetes Technol Ther

    Lived Experience of Fully Closed-Loop Insulin Delivery in Adults with Type 1 Diabetes

    Secondary analysisTechnology

  10. Diabetes Technol Ther

    Postprandial Glucose Excursions with Ultra-Rapid Insulin Analogs in Hybrid Closed-Loop Therapy for Adults with Type 1 Diabetes

    Secondary analysisTechnology

  11. Diabetes Technol Ther

    Time in Range, Time in Tight Range, and Average Glucose Relationships Are Modulated by Glycemic Variability: Identification of a Glucose Distribution Model Connecting Glycemic Parameters Using Real-World Data

    Cross-sectional studyTechnology

  12. Diabetes Technol Ther

    Impact of Flash Glucose Monitoring on the Fear of Hypoglycemia Phenomenon in Adults with Type 1 Diabetes

    Cohort studyTechnology

  13. Diabetes Technol Ther

    Glycemic Outcomes Persist for up to 2 Years in Very Young Children with the Omnipod ® 5 Automated Insulin Delivery System

    Research articleTechnology

  14. Diabetes Technol Ther

    Limitations of 14-Day Continuous Glucose Monitoring Sampling for Assessment of Hypoglycemia and Glycemic Variability in Type 1 Diabetes

    Research articleTechnology

  15. Diabetes Technol Ther

    Real-World Evidence of Omnipod ® 5 Automated Insulin Delivery System Use in 69,902 People with Type 1 Diabetes

    Cohort studyTechnology

  16. Diabetes Technol Ther

    Accuracy and Safety of the 15-Day CareSens Air Continuous Glucose Monitoring System

    Diagnostic or prognostic studyTechnology

  17. Diabetes Technol Ther

    Continuous Glucose Monitoring Systems in Noninsulin-Treated People with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

    Meta-analysisTechnology

  18. Diabetes Technol Ther

    Effect of Arterialization on Venous Blood Glucose Concentrations and Implications for Observed Continuous Glucose Monitoring Accuracy

    Mechanistic studyTechnology

  19. Diabetes Technol Ther

    Effects of Macronutrient Intake and Number of Meals on Glycemic Outcomes Over 1 Year in Youth with Type 1 Diabetes

    Secondary analysisT1D

  20. Diabetes Technol Ther

    Time in Range Is Associated with Incident Diabetic Retinopathy in Adults with Type 1 Diabetes: A Longitudinal Study

    Case-control studyComplications

  21. Diabetes Technol Ther

    Relationship Between Lipohypertrophy, Glycemic Control, and Insulin Dosing: A Systematic Meta-Analysis

    Meta-analysisT2D & other

  22. Diabetes Technol Ther

    12-Month Real-Life Efficacy of the MiniMed 780G Advanced Closed-Loop System in Patients Living with Type 1 Diabetes: A French Observational, Retrospective, Multicentric Study

    Cohort studyTechnology

  23. Diabetes Technol Ther

    Celebrating the Data from 100,000 Real-World Users of the MiniMed™ 780G System in Europe, Middle East, and Africa Collected Over 3 Years: From Data to Clinical Evidence

    Cohort studyTechnology

  24. Diabetes Technol Ther

    Early Real-World Performance of the MiniMed™ 780G Advanced Hybrid Closed-Loop System and Recommended Settings Use in the United States

    Cohort studyTechnology

  25. Diabetes Technol Ther

    Real-World Evidence of Automated Insulin Delivery System Use

    Meta-analysisTechnology

  26. Diabetes Technol Ther

    Reducing Diabetes Burden in Medtronic's Automated Insulin Delivery Systems

    Research articleTechnology

  27. Diabetes Technol Ther

    Twelve-Month Follow-up from a Randomized Controlled Trial of Simplified Meal Announcement Versus Precise Carbohydrate Counting in Adolescents with Type 1 Diabetes Using the MiniMed™ 780G Advanced Hybrid Closed-Loop System

    Randomized controlled trialTechnology

  28. Diabetes Technol Ther

    Comparator Data Characteristics and Testing Procedures for the Clinical Performance Evaluation of Continuous Glucose Monitoring Systems

    Guideline or statementTechnology

  29. Diabetes Technol Ther

    Advances in Automated Insulin Delivery with the Medtronic 780G: The Australian Experience

    Cohort studyTechnology

  30. Diabetes Technol Ther

    Aiming for the Best Glycemic Control Beyond Time in Range: Time in Tight Range as a New Continuous Glucose Monitoring Metric in Children and Adolescents with Type 1 Diabetes Using Different Treatment Modalities

    Cross-sectional studyTechnology

  31. Diabetes Technol Ther

    Diabetic Ketoacidosis at Diagnosis in Youth with Type 1 Diabetes Is Associated with a Higher Hemoglobin A1c Even with Intensive Insulin Management

    Cohort studyT1D

  32. Diabetes Technol Ther

    Diabetic Ketoacidosis at Onset of Type 1 Diabetes and Glycemic Outcomes with Closed-Loop Insulin Delivery

    Secondary analysisT1D

  33. Diabetes Technol Ther

    Efficacy of Semaglutide in Overweight and Obese Patients with Type 1 Diabetes

    Cohort studyObesity

  34. Diabetes Technol Ther

    Hybrid Closed Loop Systems Improve Glycemic Control and Quality of Life in Historically Minoritized Youth with Diabetes

    Cohort studyTechnology

  35. Diabetes Technol Ther

    Is It Time to Move Beyond TIR to TITR? Real-World Data from Over 20,000 Users of Continuous Glucose Monitoring in Patients with Type 1 and Type 2 Diabetes

    Cohort studyTechnology

  36. Diabetes Technol Ther

    Weight Gain and Glycemic Control in Adults with Type 1 Diabetes in the T1D Exchange Registry

    Cohort studyT1D

  37. Diabetes Technol Ther

    Accuracy of a Continuous Glucose Monitor During Pediatric Type 1 Diabetes Inpatient Admissions

    Cohort studyTechnology

  38. Diabetes Technol Ther

    Feasibility and Validity of In-Home Self-Collected Capillary Blood Spot Screening for Type 1 Diabetes Risk

    Diagnostic or prognostic studyT1D

  39. Diabetes Technol Ther

    Closed-Loop Insulin Delivery Systems for People with Type 1 Diabetes and Chronic Very Poor Metabolic Control: It Works and Is Safe!

    Cohort studyTechnology

  40. Diabetes Technol Ther

    The Role of a “Technology Navigator” in an Academic Diabetes Clinic: A Feasibility Evaluation

    Research articleT2D & other

All 475 Briefs in ExploreShowing Briefs 321–360 of 475, newest first